Observations placeholder
Renagel
Identifier
015696
Type of Spiritual Experience
Background
A description of the experience
Sevelamer is a phosphate binding drug used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer is currently marketed under the trade names Renagel and Renvela. Hyperphosphatemia is an electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood.
On Jan, 15, 2017 7,103 people reported to have side effects when taking Renagel.
Among them, 79 people (1.11%) have Hallucination
Time on Renagel when people have Hallucination :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Hallucination | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 0.00% | 0.00% |
Gender of people who have Hallucination when taking Renagel :
Female | Male | |
Hallucination | 53.75% | 46.25% |
Age of people who have Hallucination when taking Renagel :
0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
Hallucination | 0.00% | 0.00% | 0.00% | 5.33% | 0.00% | 9.33% | 8.00% | 77.33% |
On Jan, 15, 2017 7,103 people reported to have side effects when taking Renagel.
Among them, 285 people (4.01%) have Death